Press Releases

Date	Title	Company
20-Jul-2021	Almirall receives European Commission approval of Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis	Almirall
20-Jul-2021	PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.	PureTech
20-Jul-2021	Subscription to raise £1,000,000 to progress proprietary TYK2/JAK1 programmes into clinical development	Sareum Holdings plc
20-Jul-2021	Diagnostics firms race to reach the ‘holy grail’ of Covid testing	Snedden Campbell
20-Jul-2021	Launching today: eLearning programme to support advanced therapy training in the NHS, UK universities and government bodies	Advanced Therapy Treatment Centre (ATTC)
20-Jul-2021	Bone Therapeutics provides update on the progress of clinical studies	Bone Therapeutics
20-Jul-2021	Sputnik V vaccine against coronavirus authorized in Nigeria	Russian Direct Investment Fund
20-Jul-2021	RxCelerate Establishes Venture Capital Division and Makes First Investment in US Metabolic Disease Company	Newswire
20-Jul-2021	Paradigm4 launches REVEAL: Multi-Omics app for advanced cross-study analyses	Paradigm4
20-Jul-2021	Almost 70% of Doctors Say Covid-19 Vaccine Rates Would Be Higher If They Could Administer to Their Own Patients, New Survey Shows	B3C newswire
20-Jul-2021	BenchSci Expands Board of Directors With Appointment of Life Sciences, Tech, and Healthcare Leader Luba Greenwood	Newswire
20-Jul-2021	WHO’S TOP OF THE INBOX? RESEARCH RANKS CLINICIAN SATISFACTION WITH PHARMA’S DIGITAL CONTENT	Bryter
20-Jul-2021	nal von minden GmbH rapid test detects the Delta variant	nal von minden GmbH
20-Jul-2021	nal von minden GmbH rapid test detects the Delta variant	nal von minden GmbH
20-Jul-2021	Nass Valley Gateway Looks Ahead After Q2 Growth	Nass Valley Gateway Ltd.
20-Jul-2021	RemedyBio completes €10.5M financing from European Innovation Council	Andrew Lloyd Associates
20-Jul-2021	Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19	Roche
20-Jul-2021	US FDA approves fexinidazole as the first all-oral treatment for sleeping sickness	Sanofi
20-Jul-2021	EISAI LAUNCHES BILE ACID TRANSPORTER INHIBITOR GOOFICE® IN THAILAND	EISAI
20-Jul-2021	Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio	Thermo Fisher Scientific